Literature DB >> 1490382

Transcriptional activities of the Myc and Max proteins in mammalian cells.

L Kretzner1, E M Blackwood, R N Eisenman.   

Abstract

The myc family of oncogenes exhibit deregulated expression in a host of neoplasias. Though the molecular function of the Myc protein in both normal and tumorigenic cells has remained uncertain, it has been postulated to play a role in gene transcription on the basis of amino acid homologies with known transcription factors such as MyoD (Lüscher & Eisenman, 1990). We report here the direct testing of full-length Myc and its dimerization partner, Max, on the transcriptional activity of reporter genes bearing Myc/Max binding sites. Such reporter constructs display an endogenous level of activity in transient transfections which is dependent on the presence of the CACGTG sequence. Exogenous expression of myc results in modest activation of reporter gene transcription. Similar overexpression of max results in a repression of reporter gene activity, an effect which is reversed by co-expression with c-myc. Max repression is dependent on an intact DNA binding region, while Myc activation depends on both the N-terminal activation and the C-terminal dimerization domains. These results suggest a model in which Max homodimers can act as as repressors, and Myc-Max heterodimers as activators, of potential target genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1490382     DOI: 10.1007/978-3-642-77633-5_55

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  14 in total

1.  S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells.

Authors:  E J Fox; S C Wright
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

2.  Sin3 corepressor function in Myc-induced transcription and transformation.

Authors:  S E Harper; Y Qiu; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein.

Authors:  T Kawaguchi; M Takenoshita; T Kabashima; K Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

4.  A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1.

Authors:  A K Ghosh; M Majumder; R Steele; R A White; R B Ray
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

5.  Therapeutic Targeting of Myc.

Authors:  Edward V Prochownik; Peter K Vogt
Journal:  Genes Cancer       Date:  2010-06

6.  Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable?

Authors:  Chi Van Dang; Steven B McMahon
Journal:  Genes Cancer       Date:  2010-06

7.  Assembly of b/HLH/z proteins c-Myc, Max, and Mad1 with cognate DNA: importance of protein-protein and protein-DNA interactions.

Authors:  Jianzhong Hu; Anamika Banerjee; Dixie J Goss
Journal:  Biochemistry       Date:  2005-09-06       Impact factor: 3.162

8.  Selective utilization of basic helix-loop-helix-leucine zipper proteins at the immunoglobulin heavy-chain enhancer.

Authors:  R S Carter; P Ordentlich; T Kadesch
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

9.  Mad proteins contain a dominant transcription repression domain.

Authors:  D E Ayer; C D Laherty; Q A Lawrence; A P Armstrong; R N Eisenman
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium.

Authors:  Pawadee Lohavanichbutr; Lori C Sakoda; Christopher I Amos; Susanne M Arnold; David C Christiani; Michael P A Davies; John K Field; Eric B Haura; Rayjean J Hung; Takashi Kohno; Maria Teresa Landi; Geoffrey Liu; Yi Liu; Michael W Marcus; Grainne M O'Kane; Matthew B Schabath; Kouya Shiraishi; Stacey A Slone; Adonina Tardón; Ping Yang; Kazushi Yoshida; Ruyang Zhang; Xuchen Zong; Gary E Goodman; Noel S Weiss; Chu Chen
Journal:  Clin Cancer Res       Date:  2017-10-03       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.